Huang Q F, Gebrewold A, Zhang A, Altura B T, Altura B M
Department of Physiology, State University of New York Health Science Center at Brooklyn, New York 11203.
Am J Physiol. 1994 Jan;266(1 Pt 2):R158-63. doi: 10.1152/ajpregu.1994.266.1.R158.
Recently, attention has been drawn to the possibility that excitatory amino acids (EAAs) may play an important role in the pathogenesis of hypoxic-ischemic neuronal injury. Exaggerated release of EAAs and excessive stimulation of N-methyl-D-aspartate (NMDA) receptors and other EAA receptors have been suggested to contribute to neuronal death in ischemia and anoxia. A number of in vitro and in vivo experimental studies have shown that EAA-receptor antagonists exert a protective effect on the brain after cerebral ischemia. Because neurons are in close apposition to small intracerebral vessels, synaptically released EAAs might also regulate small blood vessel function. With the use of quantitative television microscopic observations, in vivo studies were undertaken on pial arterioles of rats. Perivascular administration of cumulative doses (10(-7)-10(-2) M) of L-glycine, L-glutamate, L-aspartate, and NMDA on the pial microvessels resulted in concentration-dependent constriction of pial arterioles (5-30% decreases in diameter) and cerebrovasospasm; the relative order of potency was aspartate > NMDA > glycine > glutamate. High concentrations of EAAs often resulted in rupture of postcapillary venules. No amine or opiate antagonist or cyclooxygenase inhibitor prevented or attenuated the effects of these putative EAAs. EAA-induced constriction and spasm of pial arterioles as well as rupture of venules could, however, be blocked by the noncompetitive NMDA-receptor antagonist MK-801 and by Mg2+. MK-801 also produced a concentration-dependent relaxation on normal pial arterioles. These results are compatible with the idea that a specific NMDA-receptor complex (RC) exists in rat cortical microvessels, which subserves vasoconstriction.(ABSTRACT TRUNCATED AT 250 WORDS)
最近,兴奋性氨基酸(EAA)可能在缺氧缺血性神经元损伤的发病机制中起重要作用这一可能性已引起关注。有人提出,EAA的过度释放以及对N-甲基-D-天冬氨酸(NMDA)受体和其他EAA受体的过度刺激,会导致缺血和缺氧时的神经元死亡。多项体外和体内实验研究表明,EAA受体拮抗剂对脑缺血后的大脑具有保护作用。由于神经元与脑内小血管紧密相邻,突触释放的EAA也可能调节小血管功能。利用定量电视显微镜观察,对大鼠软脑膜小动脉进行了体内研究。在软脑膜微血管上对L-甘氨酸、L-谷氨酸、L-天冬氨酸和NMDA进行累积剂量(10^(-7)-10^(-2) M)的血管周围给药,导致软脑膜小动脉出现浓度依赖性收缩(直径减小5-30%)和脑血管痉挛;效力的相对顺序为天冬氨酸>NMDA>甘氨酸>谷氨酸。高浓度的EAA常常导致毛细血管后小静脉破裂。没有胺类、阿片类拮抗剂或环氧化酶抑制剂能预防或减轻这些假定的EAA的作用。然而,EAA诱导的软脑膜小动脉收缩和痉挛以及小静脉破裂可被非竞争性NMDA受体拮抗剂MK-801和Mg2+阻断。MK-801对正常软脑膜小动脉也产生浓度依赖性舒张作用。这些结果与大鼠皮质微血管中存在一种特定的NMDA受体复合物(RC)的观点一致,该复合物参与血管收缩。(摘要截短于250字)